They were used on five patients, and four of them are now either in remission or cancer-free. Read more at straitstimes.com.

Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

IRVINE, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of innovative diagnostic solutions, is proud to announce that its Fortel ® Prostate Specific Antigen ...

The global BPH treatment market is expected to grow from USD 33,031.10 million in 2024 to USD 47,045.80 million by 2034, at a ...

A Keighley deli owner is taking part in clinical trials of a new drug which could transform bladder cancer treatment.

A KEIGHLEY deli owner is taking part in clinical trials of a new drug which could transform bladder cancer treatment.

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

Defense Secretary Lloyd Austin was hospitalized in 2024 and given medication that could affect his cognitive functions before he transferred his authority.

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.